Radiation may be avoidable many breast cancer patients with early-stage disease, as a study shows no survival benefit after mastectomy and lymph ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma ...
In two multicenter trials, separate balloon angioplasty platforms were noninferior to lithotripsy for treatment of calcified ...
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer This randomized phase Ib ...
The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.
Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback